Impel Neuropharma Acute Migraine Treatment
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…
On November 20, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the…
The Food and Drug Administration of the U.S. (FDA) recently authorized monoclonal antibody for treatment of COVID-19. On November 9 FDA okayed an emergency use…
On November 3, CVS Health and Alzheimer’s Association announced about team up to fight Alzheimer disease for second consecutive year. This is the second November…
On October 23, FDA (U.S. Food and Drug Administration) issued three FDA warning letters jointly with the Federal Trade Commission (FTC) to Peterson Research Laboratories…
The FDA (U. S. Food and Drug Administration) announced on October 27, about new approved lotion for nonprescription, or over-the-counter (OTC), use through a process…
Recently The U. S. Food and Drug Administration (FDA) announced about approving the first COVID-19 treatment. The antiviral drug Veklury (remdesivir) became this vaccine, it…
This October, the National Institutes of Health (NIH) began an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator…
On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…
The FDA (U.S. Food and Drug Administration) warning about fake coronavirus vaccines.“Because COVID-19 has never been seen in humans before, there are currently no vaccines…